Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study

作者：Lei Zhang, Junhui Sun, Jiansong Ji, Bin‐Yan Zhong, Guan‐Hui Zhou, Jingjing Song, Zhong-Heng Hou, Peng Huang, Shen Zhang, Zhi Li, Xiaoli Zhu, Cai‐Fang Ni · 发表于：American Journal of Roentgenology · 年份：2020 · DOI：10.2214/ajr.20.24708 · 被引用次数：36 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Liver Disease Diagnosis and Treatment、Liver Disease and Transplantation

Greater caution and closer follow-up are warranted for patients who undergo DEB-TACE for unresectable HCC than for those who undergo cTACE.